Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
7.15 USD | +0.42% | -19.66% | +386.39% |
May. 30 | FDA Grants Candel Therapeutics' CAN-3110 Orphan Drug Designation to Treat Recurrent High-Grade Glioma | MT |
May. 30 | Candel Therapeutics Gets FDA's Orphan-Drug Status for Glioma Treatment | DJ |
Business Summary
Number of employees: 42
Managers
Managers | Title | Age | Since |
---|---|---|---|
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 20-08-31 |
Founder | 66 | 01-12-31 | |
Charles Schoch
DFI | Director of Finance/CFO | 39 | - |
Seshu Tyagarajan
CTO | Chief Tech/Sci/R&D Officer | 57 | 22-03-01 |
Francesca Barone
CTO | Chief Tech/Sci/R&D Officer | 47 | 20-10-31 |
William Nichols
CTO | Chief Tech/Sci/R&D Officer | 55 | 22-09-11 |
Ileen B. Winick
HRO | Human Resources Officer | - | 20-12-31 |
Nathan Caffo
PRN | Corporate Officer/Principal | 55 | 20-08-31 |
Susan Stewart
LAW | General Counsel | 64 | 20-09-30 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Joseph Papa
BRD | Director/Board Member | 68 | 22-08-07 |
Edward Benz
BRD | Director/Board Member | 78 | 17-08-31 |
Paul Manning
CHM | Chairman | 68 | 18-10-31 |
Gary Nabel
BRD | Director/Board Member | 70 | 22-08-07 |
Founder | 66 | 01-12-31 | |
Paul-Peter Tak
CEO | Chief Executive Officer | 64 | 20-08-31 |
Renee Gaeta
BRD | Director/Board Member | 42 | 22-08-07 |
Diem Nguyen
BRD | Director/Board Member | 52 | 21-07-14 |
Director/Board Member | 45 | 18-10-31 | |
Nicoletta Loggia
BRD | Director/Board Member | - | 23-06-06 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 29,878,613 | 19,719,302 ( 66.00 %) | 122,608 ( 0.4104 %) | 66.00 % |
Company contact information
Sector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+386.39% | 213M | |
+51.85% | 57.87B | |
+41.42% | 40.25B | |
-5.25% | 39.94B | |
-5.16% | 28.54B | |
+12.79% | 26.4B | |
-20.18% | 19.33B | |
+30.88% | 12.4B | |
+0.61% | 12.23B | |
+25.06% | 12.2B |
- Stock Market
- Equities
- CADL Stock
- Company Candel Therapeutics, Inc.